Bluesky Facebook Reddit Email

Estimated COVID-19 mRNA vaccine effectiveness, illness severity during Omicron BA.4 and BA.5 periods

03.15.23 | JAMA Network

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

About The Study: In this case-control study of COVID-19 vaccines and illness, vaccine effectiveness associated with protection against medically attended COVID-19 illness was lower with increasing time since last dose; estimated vaccine effectiveness was higher after receipt of one or two booster doses compared with a primary series alone.

Authors: Ruth Link-Gelles, Ph.D., M.P.H., of the Centers for Disease Control and Prevention COVID-19 Response Team in Atlanta, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.2598)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.2598?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031523

About JAMA Network Open : JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

JAMA Network Open

Keywords

Article Information

Contact Information

JAMA Network Media Relations
JAMA Network
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2023, March 15). Estimated COVID-19 mRNA vaccine effectiveness, illness severity during Omicron BA.4 and BA.5 periods. Brightsurf News. https://www.brightsurf.com/news/LN29MPK1/estimated-covid-19-mrna-vaccine-effectiveness-illness-severity-during-omicron-ba4-and-ba5-periods.html
MLA:
"Estimated COVID-19 mRNA vaccine effectiveness, illness severity during Omicron BA.4 and BA.5 periods." Brightsurf News, Mar. 15 2023, https://www.brightsurf.com/news/LN29MPK1/estimated-covid-19-mrna-vaccine-effectiveness-illness-severity-during-omicron-ba4-and-ba5-periods.html.